Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
GLI1
REST API REST API
Homo sapiens
GLI1 is differentially expressed in 161 experiments: 85 organism parts: lung, bone marrow, ... (83 more);, 118 disease states: normal, acute myeloid leukemia, ... (116 more);, 42 cell types 224 cell lines 16 compound treatments and 54 other conditions.
Synonyms GLI
Orthologs Gli1 (Rattus norvegicus)   GLI1 (Gallus gallus)   gli1 (Danio rerio)   Gli1 (Mus musculus)   A6H727_BOVIN (Bos taurus)   Q4H3F1_CIOIN (Ciona intestinalis)   gli1.1 (Xenopus laevis)   GLI1 (Canis familiaris)   (Compare orthologs)
Gene Ontology Term epidermal cell differentiation, cytosol, DNA binding, protein binding, cytoplasm, intracellular, positive regulation of cell proliferation, metal ion binding, nucleic acid binding, smoothened signaling pathway, positive regulation of transcription from RNA polymerase II promoter, multicellular organismal development, nucleus, positive regulation of smoothened signaling pathway, positive regulation of DNA replication, regulation of smoothened signaling pathway, positive regulation of transcription, DNA-dependent, zinc ion binding, osteoblast differentiation, negative regulation of canonical Wnt receptor signaling pathway, transcription regulatory region DNA binding
InterPro Term Znf_C2H2-like, Znf_C2H2
UniProt Accession B1Q2M2, P08151, D0EUY3, E9PQQ9, E9PQQ1, E9PIB9, F5H6H8
Search EB-eye ENSG00000111087
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-15765, E-AFMX-5, E-MEXP-1251, E-MTAB-25, ... (18 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-1880, E-GEOD-22639, E-GEOD-19639, E-GEOD-2450, ... (22 experiments)

Factor Value U/D Experiments
A549
2
E-GEOD-6013, E-GEOD-3202
MDA-MB-231
1
2
E-MTAB-62, E-TABM-420, E-GEOD-5823
H2887
1
E-MTAB-62
NCI-H522
1
E-MTAB-62
ITM-E6E7-ST
1
E-GEOD-2487
HT1376
1
E-MTAB-37
218 more value(s).


Cell type

studied in E-GEOD-22373, E-GEOD-21668, E-GEOD-3920, E-GEOD-13909, E-GEOD-13987, ... (26 experiments)

Factor Value U/D Experiments
white blood cell
1
E-GEOD-2006
bronchial epithelial
1
E-MTAB-25
partially reprogrammed human induced pluripotent stem cell
1
E-GEOD-18265
B lymphocyte
1
E-GEOD-6691
immortalised T lymphocytes
1
E-GEOD-13909
1
1
E-TABM-145
36 more value(s).


Disease state

studied in E-GEOD-3307, E-MEXP-25, E-GEOD-15960, E-GEOD-1869, E-MTAB-62, ... (32 experiments)

Factor Value U/D Experiments
Huntington's disease
2
E-AFMX-6, E-GEOD-3790
gastric carcinoma
2
E-GEOD-15460, E-MTAB-37
myeloma
2
E-MTAB-372, E-MTAB-37
rhabdomyosarcoma
2
E-MTAB-37, E-MTAB-62
MDS-associated acute myeloid leukemia
1
E-MEXP-25
ischemic cardiomyopathy
1
E-MTAB-62
112 more value(s).


Compound treatment

studied in E-MEXP-1269, E-GEOD-3284, E-GEOD-6907, E-GEOD-412, E-GEOD-2292, ... (10 experiments)

Factor Value U/D Experiments
none
1
2
E-GEOD-5824, E-GEOD-412, E-MEXP-1958
5-aza-2'-deoxycytidine + trichostatin A
1
1
E-MEXP-1269
bacterial endotoxin
1
1
E-GEOD-3284
17beta-estradiol
4
1
E-GEOD-2292
unknown
1
E-GEOD-7307
Cxcl12
1
E-GEOD-7307
10 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
DMSO
1
E-GEOD-19519
thapsigargin
1
E-GEOD-19519


BioSourceProvider
studied in E-GEOD-19466, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-GEOD-19743, E-GEOD-7967, E-GEOD-21589, E-GEOD-16363

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-MEXP-1251, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Clinical treatment
studied in E-GEOD-1743, E-GEOD-6532

Developmental stage
studied in E-GEOD-19743, E-GEOD-20033, E-GEOD-3140, E-GEOD-2666

Disease staging
studied in E-GEOD-19743, E-GEOD-21887

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-GEOD-20847

Genotype
studied in E-GEOD-1923, E-GEOD-22056, E-GEOD-3494, E-GEOD-17476, E-GEOD-21750, ... (8 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234

Individual
studied in E-MTAB-197, E-TABM-325, E-GEOD-974, E-GEOD-1926, E-TABM-666, ... (20 experiments)

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214

Labeling
studied in E-LGCL-5

Material type
studied in E-MEXP-455, E-GEOD-9171

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-1801, E-AFMX-1, E-TABM-84

P53 ihc
studied in E-GEOD-21653

Phase
studied in E-GEOD-4888

Phenotype
studied in E-GEOD-22309, E-GEOD-21750

Population
studied in E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-3494, E-GEOD-6532

Protocol type
studied in E-GEOD-3254, E-GEOD-21837, E-GEOD-19246, E-GEOD-1343

RNAi
studied in E-MEXP-101, E-GEOD-3697

Sample preparation
studied in E-GEOD-16728

Sampling time point
studied in E-GEOD-19743

Sex
studied in E-GEOD-7307

Stimulation
studied in E-GEOD-20114

Subtype
studied in E-GEOD-24283

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-GEOD-1926, E-TABM-276

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-22152, E-GEOD-16837, E-GEOD-13818, E-GEOD-19815, E-GEOD-15799 ... (5 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-3494, E-GEOD-4922

Processing time: 0.316 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM